KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Non-Current Deferred Tax Liability (2016 - 2017)

Historic Non-Current Deferred Tax Liability for Travere Therapeutics (TVTX) over the last 5 years, with Q4 2017 value amounting to $16.8 million.

  • Travere Therapeutics' Non-Current Deferred Tax Liability fell 6548.25% to $16.8 million in Q4 2017 from the same period last year, while for Dec 2017 it was $16.8 million, marking a year-over-year decrease of 6548.25%. This contributed to the annual value of $16.8 million for FY2017, which is 6548.25% down from last year.
  • As of Q4 2017, Travere Therapeutics' Non-Current Deferred Tax Liability stood at $16.8 million, which was down 6548.25% from $1.2 million recorded in Q2 2017.
  • Travere Therapeutics' 5-year Non-Current Deferred Tax Liability high stood at $48.7 million for Q4 2016, and its period low was $141000.0 during Q4 2014.
  • Over the past 5 years, Travere Therapeutics' median Non-Current Deferred Tax Liability value was $12.1 million (recorded in 2016), while the average stood at $14.6 million.
  • Per our database at Business Quant, Travere Therapeutics' Non-Current Deferred Tax Liability plummeted by 9457.88% in 2014 and then soared by 1715390.07% in 2015.
  • Travere Therapeutics' Non-Current Deferred Tax Liability (Quarter) stood at $2.6 million in 2013, then tumbled by 94.58% to $141000.0 in 2014, then surged by 17153.9% to $24.3 million in 2015, then skyrocketed by 100.18% to $48.7 million in 2016, then tumbled by 65.48% to $16.8 million in 2017.
  • Its Non-Current Deferred Tax Liability stands at $16.8 million for Q4 2017, versus $1.2 million for Q2 2017 and $4.4 million for Q1 2017.